Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Commercial Services

People on the move: outsourcing jobs

By Natalie Morrison , 18-Jul-2012
Last updated on 18-Jul-2012 at 14:29 GMT presents the latest in the busy world of pharmaceutical careers, including news from PPD, Parallon, ShangPharma and C3i.

Pharmaceutical Product Development (PPD) has named Louis Renzetti VP of strategic laboratory operations.

He joins the firm from Rioche, where he was VP and global head of the RNA therapeutics division.

Lee Babiss, executive VP of global lab services and chief scientific officer, said: “His leadership will be instrumental as we continue implementing innovative new strategies to integrate our laboratory and Phase I services with our Phase II-IV services to provide clients with end-to-end, value-chain capabilities.”

Parallon Business Solutions has appointed Ed Jones as president and CEO of its Health Trust Purchasing Group and Parallon Supply Chain Solutions.

Jones takes the role after serving as interim following former CEO Jim Fitzgerald’s retirement in May.

“We are delighted to have Ed in this critically important position for Parallon. He has a very successful track record of leading strategic supply chain initiatives that have resulted in added-value improvements for our customers and our company,” said Michael O'Boyle, Parallon’s president and CEO.

Yuk Lam Lo has been appointed as the chairman of the independent committee of the company's board of directors for ShangPharma.

The news follows CEO Michael Xin Hui’s proposition to take the CRO (contract research organisation) private.

Business process outsourcing (BPO) firm C3i has drafted in Jonathan Song as business development executive in Asia.

He will support C3i's strategy to expand its clinical and commercial solutions to pharmaceutical, biotechnology and clinical research organisations in the region.

Dave Hanaman, chief sales and marketing officer and co-founder at C3i, said: "His professionalism, customer-focus, and innovative approach to business development will catalyse our growth in Asia and help us to meet our customers' unique needs in this important and rapidly evolving market."

Inclinix-PMG Holdings has appointed John Rubino, Jennifer Byrne and Denise Robinson onto its leadership team.

Joining the firm from Raleigh Medical Group (RMG) Rubino will become medical director for the entire group as well as principal investigator advisory board.

Byrne has been named president and chief operating officer of research at PMG, whilst

Robinson will become president and chief operating officer of Inclinix.

"Together Inclinix and PMG Research bring forth an unrivaled precedent for research site-based experience which will allow for better outcomes for pharmaceutical sponsors, physician investigators, and research participants," Byrne said.

Cadient Group has hired Gabrielle Pastore to lead the healthcare commercial services agency’s newly formed commercial innovation group.

She will take the role of VP of commercial strategy and innovation.

Will Reese, chief innovation officer, said: "She thinks creatively, leads collaboratively, and has extensive global experience building brand value through innovation while producing significant and sustainable business growth."

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE

All Gallery

Movers and shakers in outsourcing

Movers and shakers in outsourcing

This week's round-up of who's going places in contract research, manufacturing and services.

In pictures: People on the Move in outsourcing

In pictures: People on the Move in outsourcing

The latest faces in drug discovery, CROs, and research charities.

Who's the next big thing in outsourcing?

Who's the next big thing in outsourcing?

Results from the 50 Most Influential People in Vaccines, Aligent changes CEOs, and more...

Scottish referendum: we look at Scotland's Nobel drug contributions

Nobel prizes and the world’s top drug: a gallery of Scottish pharma

On the eve of the historical vote on Scottish independence from the UK tomorrow, we take a...